TNFSF10 and cancer: As G0/G1 cell cycle arrest was previously reported to sensitize cancer cells against TRAIL [40] and epigenetic modulators were often reported to be TRAIL sensitizers [41, 42], we assessed the effect of Iso-3 on cancer cell viability after combination treatments with TRAIL.